<DOC>
	<DOCNO>NCT01212562</DOCNO>
	<brief_summary>The purpose study evaluate efficacy cryosurgery continue imiquimod application treatment basal cell carcinoma skin .</brief_summary>
	<brief_title>Treatment Primary Basal Cell Carcinomas Skin With Combination Topical Imiquimod Cryosurgery</brief_title>
	<detailed_description>Evaluation efficacy : - Number patient : N=50 - Inclusion criterion : Basal cell carcinoma skin proven biopsy - Exclusion criterion : ( 1 ) Size tumor &gt; 2cm ; ( 2 ) Distance eyelid &lt; 1cm ; ( 3 ) Number tumor &gt; 5 Treatment protocol : Patients apply imiquimod daily 14 day tumor rim 2mm around tumor . On day 14 session mild cryosurgery ( 2 cycle 10-15 second , open spray liquid nitrogen ) apply patient continue application imiquimod another 3 week evaluate . Persisting erosion consider persistence tumor imiquimod continue another 3 week with/or without cryosurgery session . The patient evaluate 1,3,6,12 month discontinuation imiquimod yearly thereafter relapse . In case clinical relapse , confirm biopsy .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Basal cell carcinoma skin Size &lt; = 2cm Number tumor &lt; = 5 Distance eyelid , mouth &gt; 1cm Size &gt; 2cm Number tumor &gt; 5 Distance eyelid mouth &lt; = 1cm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>basal cell carcinoma</keyword>
	<keyword>cryosurgery</keyword>
	<keyword>imiquimod</keyword>
	<keyword>immunocryosurgery</keyword>
</DOC>